Free Trial
The Market Does Not Wait. MarketBeat All Access for Just $149
Get the Deal
Claim MarketBeat All Access Sale Promotion

Fortress Biotech (FBIOP) Competitors

Fortress Biotech logo
$16.26 +0.16 (+0.96%)
As of 12:33 PM Eastern
This is a fair market value price provided by Massive. Learn more.

FBIOP vs. AIMDW, ALVOW, ARAV, ACABW, and RNA

Should you buy Fortress Biotech stock or one of its competitors? MarketBeat compares Fortress Biotech with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Fortress Biotech include Ainos (AIMDW), Alvotech (ALVOW), Aravive (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), and Avidity Biosciences (RNA). These companies are all part of the "pharmaceutical products" industry.

How does Fortress Biotech compare to Ainos?

Fortress Biotech (NASDAQ:FBIOP) and Ainos (NASDAQ:AIMDW) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, analyst recommendations, media sentiment, earnings, valuation, institutional ownership, dividends and profitability.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fortress Biotech$66.16MN/AN/AN/AN/A
Ainos$18.11KN/AN/AN/AN/A

In the previous week, Fortress Biotech had 1 more articles in the media than Ainos. MarketBeat recorded 2 mentions for Fortress Biotech and 1 mentions for Ainos. Fortress Biotech's average media sentiment score of 0.00 equaled Ainos'average media sentiment score.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Fortress Biotech
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Ainos
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Company Net Margins Return on Equity Return on Assets
Fortress BiotechN/A N/A N/A
Ainos N/A N/A N/A

Summary

Fortress Biotech beats Ainos on 2 of the 2 factors compared between the two stocks.

How does Fortress Biotech compare to Alvotech?

Alvotech (NASDAQ:ALVOW) and Fortress Biotech (NASDAQ:FBIOP) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, media sentiment, profitability, valuation, earnings, risk and institutional ownership.

In the previous week, Fortress Biotech had 2 more articles in the media than Alvotech. MarketBeat recorded 2 mentions for Fortress Biotech and 0 mentions for Alvotech. Alvotech's average media sentiment score of 0.00 equaled Fortress Biotech'saverage media sentiment score.

Company Overall Sentiment
Alvotech Neutral
Fortress Biotech Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alvotech$586.32MN/AN/AN/AN/A
Fortress Biotech$66.16MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
AlvotechN/A N/A N/A
Fortress Biotech N/A N/A N/A

Summary

Alvotech and Fortress Biotech tied by winning 1 of the 2 factors compared between the two stocks.

How does Fortress Biotech compare to Aravive?

Fortress Biotech (NASDAQ:FBIOP) and Aravive (NASDAQ:ARAV) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, risk, media sentiment, profitability, valuation, dividends and earnings.

In the previous week, Fortress Biotech had 2 more articles in the media than Aravive. MarketBeat recorded 2 mentions for Fortress Biotech and 0 mentions for Aravive. Fortress Biotech's average media sentiment score of 0.00 equaled Aravive'saverage media sentiment score.

Company Overall Sentiment
Fortress Biotech Neutral
Aravive Neutral

Company Net Margins Return on Equity Return on Assets
Fortress BiotechN/A N/A N/A
Aravive N/A N/A N/A

35.8% of Aravive shares are owned by institutional investors. 60.4% of Aravive shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fortress Biotech$66.16MN/AN/AN/AN/A
AraviveN/AN/AN/A-$0.90N/A

Summary

Fortress Biotech and Aravive tied by winning 2 of the 4 factors compared between the two stocks.

How does Fortress Biotech compare to Atlantic Coastal Acquisition Corp. II?

Fortress Biotech (NASDAQ:FBIOP) and Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) are both pharmaceutical products companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, institutional ownership, dividends, profitability, earnings, valuation and media sentiment.

In the previous week, Fortress Biotech had 2 more articles in the media than Atlantic Coastal Acquisition Corp. II. MarketBeat recorded 2 mentions for Fortress Biotech and 0 mentions for Atlantic Coastal Acquisition Corp. II. Fortress Biotech's average media sentiment score of 0.00 equaled Atlantic Coastal Acquisition Corp. II'saverage media sentiment score.

Company Overall Sentiment
Fortress Biotech Neutral
Atlantic Coastal Acquisition Corp. II Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fortress Biotech$66.16MN/AN/AN/AN/A
Atlantic Coastal Acquisition Corp. IIN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Fortress BiotechN/A N/A N/A
Atlantic Coastal Acquisition Corp. II N/A N/A N/A

Summary

Fortress Biotech beats Atlantic Coastal Acquisition Corp. II on 2 of the 2 factors compared between the two stocks.

How does Fortress Biotech compare to Avidity Biosciences?

Avidity Biosciences (NASDAQ:RNA) and Fortress Biotech (NASDAQ:FBIOP) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings.

Fortress Biotech has higher revenue and earnings than Avidity Biosciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Avidity Biosciences$36.68M6.09-$322.30MN/AN/A
Fortress Biotech$66.16MN/AN/AN/AN/A

In the previous week, Avidity Biosciences had 3 more articles in the media than Fortress Biotech. MarketBeat recorded 5 mentions for Avidity Biosciences and 2 mentions for Fortress Biotech. Avidity Biosciences' average media sentiment score of 0.80 beat Fortress Biotech's score of 0.00 indicating that Avidity Biosciences is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Avidity Biosciences
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Fortress Biotech
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Fortress Biotech has a net margin of 0.00% compared to Avidity Biosciences' net margin of -3,650.39%. Fortress Biotech's return on equity of 0.00% beat Avidity Biosciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Avidity Biosciences-3,650.39% -44.92% -39.57%
Fortress Biotech N/A N/A N/A

Avidity Biosciences presently has a consensus target price of $69.42, indicating a potential upside of 431.96%. Given Avidity Biosciences' stronger consensus rating and higher probable upside, analysts clearly believe Avidity Biosciences is more favorable than Fortress Biotech.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Avidity Biosciences
1 Sell rating(s)
11 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.37
Fortress Biotech
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

Avidity Biosciences beats Fortress Biotech on 6 of the 10 factors compared between the two stocks.

Get Fortress Biotech News Delivered to You Automatically

Sign up to receive the latest news and ratings for FBIOP and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FBIOP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FBIOP vs. The Competition

MetricFortress BiotechBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$462.13M$6.29B$12.07B
Dividend Yield12.11%3.86%2.80%5.32%
P/E RatioN/A3.8020.6225.05
Price / SalesN/A7,455.24545.5877.63
Price / CashN/A13.1327.4837.30
Price / BookN/A84.129.736.60
Net IncomeN/A-$96.07M$3.55B$335.50M
7 Day Performance21.85%0.84%-1.86%-1.91%
1 Month Performance22.59%0.12%-3.69%-1.84%
1 Year Performance143.34%69.11%29.52%27.02%

Fortress Biotech Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FBIOP
Fortress Biotech
N/A$16.26
+1.0%
N/A+142.8%$0.00$66.16MN/A170
AIMDW
Ainos
N/A$0.08
+15.9%
N/A-54.3%$0.00$124.16KN/A40
ALVOW
Alvotech
N/A$0.25
flat
N/A-87.9%$0.00$586.32MN/A4
ARAV
Aravive
N/A$0.04
flat
N/AN/A$0.00N/AN/A20
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.00
flat
N/AN/A$0.00N/AN/A15

Related Companies and Tools


This page (NASDAQ:FBIOP) was last updated on 5/19/2026 by MarketBeat.com Staff.
From Our Partners